Robert Spiegel's Trading History
| GERNGeron | Oct 01, 2026 | Director | Uninformative Buy | 7.81K | $189.67K | |
| RNXTRenovoRx | Jan 30, 2024 | Director | Uninformative Buy | ― | $54.51K | |
| BGMSBio Green Med Solution | Jul 03, 2023 | Director | Uninformative Buy | ― | $35.47K | |
| ATNXQAthenex | Apr 24, 2023 | ― | Uninformative Buy | 2.99K | $68.88 | |
| PDSBPDS Biotechnology | Mar 18, 2019 | Director | Uninformative Buy | 5.03K | $70.07K | |
| SCMPSucampo Pharmaceuticals | Feb 13, 2018 | ― | Uninformative Sell | 92.34K | $0.00 | |
| PTCTPTC Therapeutics | Mar 13, 2015 | CMO | Uninformative Sell | 77.35K | $194.24K | |
| TLONTalon Therapeutics Inc | ― | ― | ― | ― | ||
| AYLAAyala Pharmaceuticals | ― | ― | ― | ― | ||
| ADXSAdvaxis | ― | ― | ― | ― |
You May Also Like
Robert Spiegel insider profile FAQ
What stocks does Robert Spiegel hold?
Robert Spiegel holds: GERN, BGMS, PTCT, ADXS, PDSB, ATNXQ, AYLA, RNXT, SCMP, TLON stocks.
What was Robert Spiegel’s latest transaction?
Robert Spiegel’s latest transaction was an Uninformative Buy of $7.81K.
What is Robert Spiegel's role in Geron?
Robert Spiegel's role in Geron is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.